| scholarly article | Q13442814 |
| P2093 | author name string | Yuan Wang | |
| Jingfang Ju | |||
| Debabrata Banerjee | |||
| Glenn Merlino | |||
| Pravin J Mishra | |||
| Bo Song | |||
| Joseph R Bertino | |||
| Prasun J Mishra | |||
| Rita Humeniuk | |||
| P2860 | cites work | p16(INK4a) translation suppressed by miR-24 | Q21092220 |
| Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme | Q24337187 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements | Q24656666 | ||
| Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation | Q24658400 | ||
| A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance | Q24679991 | ||
| Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
| An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans | Q27860895 | ||
| Identification of novel genes coding for small expressed RNAs | Q27860917 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4 | Q28251320 | ||
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
| MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells | Q33385138 | ||
| MicroRNA polymorphisms: a giant leap towards personalized medicine | Q33812664 | ||
| Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. | Q34724529 | ||
| Dynamic regulation of miRNA expression in ordered stages of cellular development. | Q35677284 | ||
| MicroRNAs as oncogenes | Q36345302 | ||
| miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes | Q36454391 | ||
| MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics | Q37138992 | ||
| MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine | Q37249048 | ||
| MicroRNA reexpression as differentiation therapy in cancer | Q37286627 | ||
| miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells | Q39859199 | ||
| Characterization of function and regulation of miR-24-1 and miR-31. | Q39873307 | ||
| Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile | Q39889779 | ||
| Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. | Q40032085 | ||
| Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells. | Q40119524 | ||
| Exploration of human miRNA target genes in neuronal differentiation | Q40199885 | ||
| Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine | Q44060230 | ||
| Pharmacogenomics of microRNA: a miRSNP towards individualized therapy | Q46845992 | ||
| A gene for dihydrofolate reductase in a herpesvirus | Q48327700 | ||
| A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours | Q48368788 | ||
| Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells. | Q53473105 | ||
| Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol | Q70265337 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e8445 | |
| P577 | publication date | 2009-12-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism | |
| P478 | volume | 4 |
| Q39072564 | Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells |
| Q31133417 | Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta |
| Q38200600 | Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance |
| Q30528601 | Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart |
| Q36216104 | Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer |
| Q82534572 | Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions |
| Q38500323 | Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes |
| Q93083289 | Circular RNAs in cancer: new insights into functions and implications in ovarian cancer |
| Q38503895 | Circulating miRNAs as biomarkers for endocrine disorders |
| Q50934746 | Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden. |
| Q53663105 | Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior. |
| Q35752431 | Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in Humans |
| Q37639167 | Evaluation of the mirn23a Cluster through an iTRAQ-based Quantitative Proteomic Approach |
| Q91529697 | Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: A meta-analysis |
| Q34177121 | Genetic variation in microRNA networks: the implications for cancer research |
| Q28741878 | Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons |
| Q36310047 | Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. |
| Q37799873 | Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis |
| Q38370358 | Implications of miRNAs in Colorectal Cancer Chemoresistance |
| Q42094255 | Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells |
| Q36192675 | Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy |
| Q34778041 | Integrating microRNAs into a system biology approach to acute lung injury |
| Q37087420 | Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis |
| Q33948651 | Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases |
| Q34646522 | Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation |
| Q37728744 | Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy |
| Q36210780 | MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. |
| Q37034049 | MicroRNA expression and its association with DNA repair in preimplantation embryos |
| Q37809919 | MicroRNA in colorectal cancer: from benchtop to bedside |
| Q41223735 | MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. |
| Q34417467 | MicroRNAs as promising biomarkers in cancer diagnostics |
| Q58923813 | MicroRNAs in Cancer Drug Resistance and Drug Sensitivity |
| Q39090370 | MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. |
| Q42859430 | MicroRNA‐24 regulates the processing of latent TGFβ1 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN |
| Q34404162 | Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis |
| Q37407242 | Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. |
| Q35987115 | Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma |
| Q33648268 | Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells |
| Q34490037 | Regulation of TRIB3 mRNA and protein in breast cancer |
| Q35164003 | Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart |
| Q33862088 | Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer |
| Q37699330 | TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer |
| Q86809678 | Technical Aspects Related to the Analysis of Circulating microRNAs |
| Q28579249 | Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins |
| Q40740405 | The Beginning of the Road for Non-Coding RNAs in Normal Hematopoiesis and Hematologic Malignancies |
| Q35599477 | The emerging role of microRNAs in drug responses |
| Q36299753 | The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins |
| Q36907062 | The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis. |
| Q33700623 | Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV |
| Q38977601 | Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer |
| Q39434683 | Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. |
| Q58093552 | Up-regulation of miR-24-1-5p is involved in the chemoprevention of colorectal cancer by black raspberry anthocyanins |
| Q58758617 | hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis |
| Q38771877 | miR clusters target cellular functional complexes by defining their degree of regulatory freedom |
| Q40058632 | miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas |
| Q42250602 | miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes |
| Q37764707 | miRNAs as biomarkers in colorectal cancer diagnosis and prognosis |
Search more.